Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,006 DKK | +0.30% |
|
+1.79% | +44.05% |
12:42pm | India plans incentives for diabetes, obesity drug makers in 2026, government official says | RE |
09:22am | NOVO NORDISK : UBS gives a Neutral rating | ZD |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.05% | 64TCr | |
+56.12% | 82TCr | |
-6.98% | 35TCr | |
+17.39% | 33TCr | |
+9.51% | 30TCr | |
+16.57% | 24TCr | |
+2.04% | 23TCr | |
+13.31% | 22TCr | |
+8.08% | 17TCr | |
-2.85% | 16TCr |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- NOVO NORDISK : Deutsche Bank remains its Buy rating